Pharmacokinetics of lomefloxacin in renally compromised patients.
The single-dose pharmacokinetics of orally administered lomefloxacin (400 mg) were studied in normal subjects and in patients with various degrees of renal function. The subjects were classified by creatinine clearance (CLCR) normalized for body surface area: group 1, CLCR of greater than 80 ml/min/...
Sparad:
| I publikationen: | Antimicrob Agents Chemother |
|---|---|
| Huvudupphov: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
1990
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172062/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2088191/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.12.2364 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|